Welcome to chemicalbook!
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

Fatostatin A

Fatostatin A Structure
  • ₹12329.68 - ₹65545.38
  • Product name: Fatostatin A
  • CAS: 298197-04-3
  • MF: C18H19BrN2S
  • MW: 375.33
  • EINECS:
  • MDL Number:MFCD00760867
  • Synonyms:Fatostatin A;4-[4-(4-Methylphenyl)-2-thiazolyl]-2-propylpyridine MonohydrobroMide;Fatostatin A HydrobroMide;2-(2-propylpyridin-4-yl)-4-p-tolylthiazole hydrobromide;25B11 hydrobromide;4-[4-(4-methylphenyl)-2-thiazolyl]-2-propylpyridine hydrobromide;Fatostatin hydrobromide;Fatostatin
3 prices
Selected condition:

Brand

  • Sigma-Aldrich(India)

Package

  • 5MG
  • 25MG
  • ManufacturerSigma-Aldrich(India)
  • Product numberF8932
  • Product descriptionFatostatin hydrobromide ≥98% (HPLC), powder
  • Packaging5MG
  • Price₹12329.68
  • Updated2022-06-14
  • Buy
  • ManufacturerSigma-Aldrich(India)
  • Product number341329
  • Product descriptionFatostatin - CAS 298197-04-3 - Calbiochem A cell-permeable diarylthiazole compound that prevents the cellular activation of the SREBP-1/2 precursors to the active nuclear forms by blocking SRE
  • Packaging25MG
  • Price₹15469.99
  • Updated2022-06-14
  • Buy
  • ManufacturerSigma-Aldrich(India)
  • Product numberF8932
  • Product descriptionFatostatin hydrobromide ≥98% (HPLC), powder
  • Packaging25MG
  • Price₹65545.38
  • Updated2022-06-14
  • Buy
Manufacturer Product number Product description Packaging Price Updated Buy
Sigma-Aldrich(India) F8932 Fatostatin hydrobromide ≥98% (HPLC), powder 5MG ₹12329.68 2022-06-14 Buy
Sigma-Aldrich(India) 341329 Fatostatin - CAS 298197-04-3 - Calbiochem A cell-permeable diarylthiazole compound that prevents the cellular activation of the SREBP-1/2 precursors to the active nuclear forms by blocking SRE 25MG ₹15469.99 2022-06-14 Buy
Sigma-Aldrich(India) F8932 Fatostatin hydrobromide ≥98% (HPLC), powder 25MG ₹65545.38 2022-06-14 Buy

Properties

storage temp. :2-8°C
solubility :DMSO: ≥10mg/mL
form :powder
color :light yellow to yellow

Safety Information

Symbol(GHS): GHS hazard pictograms
Signal word: Warning
Hazard statements:
Code Hazard statements Hazard class Category Signal word Pictogram P-Codes
H302 Harmful if swallowed Acute toxicity,oral Category 4 Warning GHS hazard pictograms P264, P270, P301+P312, P330, P501
H315 Causes skin irritation Skin corrosion/irritation Category 2 Warning GHS hazard pictograms P264, P280, P302+P352, P321,P332+P313, P362
H319 Causes serious eye irritation Serious eye damage/eye irritation Category 2A Warning GHS hazard pictograms P264, P280, P305+P351+P338,P337+P313P
H335 May cause respiratory irritation Specific target organ toxicity, single exposure;Respiratory tract irritation Category 3 Warning GHS hazard pictograms
Precautionary statements:
P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

Description

Sterol regulatory element binding proteins (SREBPs) are transcription factors that have pivotal roles in lipogenesis and fat metabolism. The activation of SREBPs requires escort to the Golgi by SREBP cleavage-activating protein (SCAP) followed by proteolytic release of SREBP from the Golgi. Fatostatin is an inhibitor of SREBP activation, preventing SCAP-mediated escort of either SREBP-1 or SREBP-2 to the Golgi (IC50 = 5.6 μM). This blocks constitutive SREBP-mediated gene expression in the human prostate cancer cell line DU145. Fatostatin prevents insulin-induced adipogenesis of 3T3-L1 cells as well as growth induced by insulin-like growth factor 1 in DU145 cells (IC50 = 0.1 μM). Through its actions on SCAP/SREBP-1, it inhibits high glucose-induced upregulation of TGF-β in primary rat mesangial cells. This compound also alters lipid metabolism in vivo, reducing hepatic fat accumulation in ob/ob mice.

More related product prices

TMC-207 902135-91-5 XL-647